Creative Medical Technology
CELZ
8 hedge funds and large institutions have $90.4K invested in Creative Medical Technology in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.06% less ownership
Funds ownership: 1.48% → 1.42% (-0.06%)
13% less capital invested
Capital invested by funds: $104K → $90.4K (-$13.9K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ODG
O'Dell Group
Cincinnati,
Ohio
|
+$5 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$4.92K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.38K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$228 |
| 4 |
Wells Fargo
San Francisco,
California
|
-$87 |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$9 |
CELZ Hedge Fund Activity: Q4 2023 in Review
8 of the 6,868 institutional investors tracked by Wall St. Rank reported a position in Creative Medical Technology (CELZ) for Q4 2023, worth a combined $90.4K — down 13% from $104K a quarter earlier.
Fund positioning in CELZ was balanced in Q4 2023: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 4 trimmed.
The largest buyer was O'Dell Group, opening a new position worth an estimated $5. The largest seller was Federation des caisses Desjardins du Quebec, exiting entirely with an estimated $4.92K sold.
- 8 institutional investors held Creative Medical Technology (CELZ) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $90.4K of Creative Medical Technology stock for Q4 2023, down 13% quarter-over-quarter.
- 1 fund opened new Creative Medical Technology positions in Q4 2023 and 1 closed out, a net change of 0 holders.
- The largest Creative Medical Technology buyer in Q4 2023 was O'Dell Group, an estimated $5 added.
- The largest Creative Medical Technology seller in Q4 2023 was Federation des caisses Desjardins du Quebec, an estimated $4.92K sold.
Based on aggregated 13F filings for Q4 2023.